ZIVO Bioscience and Tianjin Norland Biotech Execute Letter of Intent to Produce ZIVO Algae Strain in China for International and Domestic Markets
ZIVO Bioscience, Inc. , a biotech/agtech R&D company engaged in the commercialization of nutritional and medicinal products derived from proprietary algal strains, has announced the execution of a letter of intent to produce its proprietary algae strain at Tianjin Norland Biotech (Norland) facilities in China. Norland is one of the largest producers of algae in China, […]